<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312"><FONT color=#000000>牛股回首，布局龙头<SPAN lang=EN-US><?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></FONT></SPAN></B></P>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312"><FONT color=#000000>中国平安<SPAN lang=EN-US>601318</SPAN>现价<SPAN lang=EN-US>140</SPAN>元 <SPAN lang=EN-US><o:p></o:p></SPAN></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><FONT color=#000000><SPAN lang=EN-US style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312">1)</SPAN><SPAN style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312">投连险是拉动<SPAN lang=EN-US> 2007 </SPAN>年寿险保费增长的重要动力 <SPAN lang=EN-US><o:p></o:p></SPAN></SPAN></FONT></P>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt 14pt; TEXT-INDENT: -14pt; mso-char-indent-count: -1.0"><FONT color=#000000><SPAN lang=EN-US style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312">2)</SPAN><SPAN style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312">投连险的价值，不仅在于对保险公司的经营和财务有多种好处，更重要的是具有收益贡献和规避风险的双重功能 <SPAN lang=EN-US><o:p></o:p></SPAN></SPAN></FONT></P>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt 14pt; TEXT-INDENT: -14pt; mso-char-indent-count: -1.0"><FONT color=#000000><SPAN lang=EN-US style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312">3)</SPAN><SPAN style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312">股权投资收益仍有较大释放空间 <SPAN lang=EN-US><o:p></o:p></SPAN></SPAN></FONT></P>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt 14pt; TEXT-INDENT: -14pt; mso-char-indent-count: -1.0"><FONT color=#000000><SPAN lang=EN-US style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312">4)</SPAN><SPAN style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312">中国平安<SPAN lang=EN-US> 2007 </SPAN>年、<SPAN lang=EN-US>2008 </SPAN>年每股净收益分别为<SPAN lang=EN-US>2.52</SPAN>、<SPAN lang=EN-US>3.5 </SPAN>元。<SPAN lang=EN-US><o:p></o:p></SPAN></SPAN></FONT></P>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt 14pt; TEXT-INDENT: -14pt; mso-char-indent-count: -1.0"><SPAN lang=EN-US style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312"><o:p><FONT color=#000000> </FONT></o:p></SPAN></P>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt 14pt; TEXT-INDENT: -14pt; mso-char-indent-count: -1.0"><FONT color=#000000><SPAN lang=EN-US style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312">000423</SPAN><SPAN style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312">东阿阿胶现价<SPAN lang=EN-US>24.89<o:p></o:p></SPAN></SPAN></FONT></P>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt 14pt; TEXT-INDENT: -14pt; mso-char-indent-count: -1.0"><FONT color=#000000><SPAN lang=EN-US style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312">1</SPAN><SPAN style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312">）民族品牌，公司阿胶块作为资源型产品的持续提价能力。 <SPAN lang=EN-US><o:p></o:p></SPAN></SPAN></FONT></P>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt 14pt; TEXT-INDENT: -14pt; mso-char-indent-count: -1.0"><FONT color=#000000><SPAN lang=EN-US style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312">2</SPAN><SPAN style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312">）公司<SPAN lang=EN-US>4 </SPAN>个阿胶系列化产品（阿胶、复方阿胶浆、阿胶补血颗粒和补血膏）将在公司快速提升的营销管理能力的强有力地推动下，进一步扩大补血市场的绝对领导份额 <SPAN lang=EN-US><o:p></o:p></SPAN></SPAN></FONT></P>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt 14pt; TEXT-INDENT: -14pt; mso-char-indent-count: -1.0"><FONT color=#000000><SPAN lang=EN-US style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312">3</SPAN><SPAN style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312">）持续推出的高端保健品新品将带动保健食品跨越式增长，公司有望成长为具有传统品牌优势的阿胶保健品大鳄。<SPAN lang=EN-US><o:p></o:p></SPAN></SPAN></FONT></P>
<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt 14pt; TEXT-INDENT: -14pt; mso-char-indent-count: -1.0"><FONT color=#000000><SPAN lang=EN-US style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312">4</SPAN><SPAN style="FONT-SIZE: 14pt; FONT-FAMILY: 楷体_GB2312">）技术面配合，长阴线杀到箱底和重要均线位置<SPAN lang=EN-US><o:p></o:p></SPAN></SPAN></FONT></P>

[ 本帖最后由 红色海浪 于 2007-10-25 23:13 编辑 ]

怎么也要钱，我穷！可买不起！

股市牛 不过都过去了 现在还是少碰